drugset / Trial / NCT06710600

Phototoxicity of Frequently Prescribed Medicines

NCT06710600

Completed 12 enrolled Medical University of Vienna
RandomizedParallel-groupSingle-blindOther

Summary

This pilot trial aims to study 10 selected commonly prescribed medicines with different grade of phototoxic potential. As there is no currently established way to assess phototoxic potential in a systematic and quantitative way, we want to test a novel radiation and measurement protocol to provide more granular information for patients and providers.

Timeline

Start
2022-09-22
Primary completion
2024-04-09
Completion
2024-10-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Amiodarone Small molecule 200 mg Oral
Subject Aspirin Small molecule 500 mg Oral
Subject Diclofenac Other / unclassified 100 mg Oral
Subject Doxycycline Small molecule 200 mg Oral
Subject Enalapril Other / unclassified 10 mg Oral
Subject Furosemide Other / unclassified 40 mg Oral
Subject Hydrochlorothiazide Unknown 25 mg Oral
Subject Pantoprazole Other / unclassified 40 mg Oral
Subject Verapamil Other / unclassified 80 mg Oral
Subject Voriconazole Small molecule 200 mg Oral